S. Meis

Synthesis and Structure−Activity Relationships of Suramin-Derived P2Y11 Receptor Antagonists with Nanomolar Potency

G. Schmalzing, J. Boeynaems, M. Kassack, 2005 .

Inhibition of Neutrophil Apoptosis by ATP Is Mediated by the P2Y11 Receptor1

A. Surprenant, C. Bingle, M. Kassack, 2007, The Journal of Immunology.

NF546 [4,4′-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene-α,α′-diphosphonic Acid) Tetrasodium Salt] Is a Non-Nucleotide P2Y11 Agonist and Stimulates Release of Interleukin-8 from Human Monocyte-Derived Dendritic Cells

G. Schmalzing, J. Boeynaems, A. Hamacher, 2010, Journal of Pharmacology and Experimental Therapeutics.

Extracellular NAD+ Is an Agonist of the Human P2Y11 Purinergic Receptor in Human Granulocytes*

L. Sturla, C. Usai, I. Moreschi, 2006, Journal of Biological Chemistry.

Mediated by the P 2 Y Inhibition of Neutrophil Apoptosis by ATP Is

A. Surprenant, M. Kassack, L. Stokes, 2007 .

New iantherans from the marine sponge Ianthella quadrangulata: novel agonists of the P2Y(11) receptor.

M. Kassack, S. Kehraus, A. Wright, 2007, Journal of medicinal chemistry.

The Suramin Analog 4,4′,4″,4″′-(Carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kis-benzenesulfonic Acid (NF110) Potently Blocks P2X3 Receptors: Subtype Selectivity Is Determined by Location of Sulfonic Acid Groups

G. Schmalzing, P. Illés, M. Kassack, 2006, Molecular Pharmacology.